7ILT

Group deposition for crystallographic fragment screening of SARS-CoV-2 nucleocapsid protein (CTD) -- Crystal Structure of SARS-CoV-2 nucleocapsid protein (CTD) in complex with Z1545313172 (Nprot-x0190)

7ILT の概要

• エントリーDOI: 10.2210/pdb7ilt/pdb
• Group deposition: Group deposition for crystallographic fragment screening of SARS-CoV-2 nucleocapsid protein (CTD) (G_1002353)
• 分子名称: Nucleoprotein, (2~{S})-~{N}-(4-aminocarbonylphenyl)oxolane-2-carboxamide (3 entities in total)
• 機能のキーワード: diamond i04-1, pandda2, xchemexplorer, crystallographic fragment screening, sars-cov-2, nucleocapsid protein, n protein, viral protein
• 由来する生物種: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2); 詳細
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 13352.99

構造登録者

Aschenbrenner, J.C.,Luptak, J.,Balcomb, B.H.,Marples, P.G.,Bellini, D.,Yu, C.W.,Douangamath, A.,Dias, A.,Powell, A.,Fearon, D.,James, L.,von Delft, F. (登録日: 2025-08-11, 公開日: 2026-08-26)

• 主引用文献: Luptak, J.,Aschenbrenner, J.C.,Balcomb, B.H.,Marples, P.G.,Bellini, D.,Yu, C.W.,Douangamath, A.,Dias, A.,Powell, A.,Fearon, D.,James, L.,von Delft, F.; Group deposition for crystallographic fragment screening of SARS-CoV-2 nucleocapsid protein (CTD); To Be Published,

実験手法

X-RAY DIFFRACTION (1.72 Å)